Here is a fact about the alcohol industry that took a surprisingly long time for anyone to build a company around: most people who want to drink less do not want to stop drinking. This sounds obvious, and it is obvious, and yet the entire recovery apparatus - the meetings, the chips, the sobriety dates - is built on the premise that the only respectable amount is zero. If you are a person who thinks "I had six beers this week and I'd feel better with three," that apparatus has essentially nothing for you. It hands you a binary and you don't fit in either box.
Sunnyside, a San Francisco company founded in 2020, is a bet on the space between the boxes. Its pitch is moderation, not abstinence: track what you drink the way you'd track calories or steps, get a real human coach texting you, join a community of people doing the same thing, and - if you want the pharmacological assist - talk to a licensed clinician about naltrexone. The company says 600,000-plus people have used it to avoid more than 24 million drinks. Members report cutting weekly consumption by about a third, a figure Sunnyside says has been third-party verified.
The interesting thing is not that the number is big. The interesting thing is that the number exists at all, because "drink somewhat less" has historically been an un-fundable, un-measurable, faintly embarrassing goal. Sunnyside's whole enterprise is the argument that it shouldn't be.
The founders built the app they wish their families had
Sunnyside was co-founded by Nick Allen, its CEO, and Ian Andersen, its chief growth officer. Both grew up with alcoholic parents. Allen's household had both parents in recovery; Andersen lost his mother to alcohol-related illness when he was eleven. This is the kind of origin story that would be manipulative if a marketing team invented it and is instead just the actual reason the company exists.
Allen, previously head of growth at Lyft for Business, did not start out to build a startup. During the 2020 lockdown - when a lot of people were, quietly, drinking more - he built a rough tracking system for himself, trying to manage alcohol the way he'd learned to manage diet and exercise. It worked well enough that he and Andersen shipped a scrappy version to the public in mid-2020 under the name Cutback Coach. Early engagement was good enough to land a seed round that December. The company rebranded to Sunnyside in late 2021.
What you actually do with it
Mechanically, Sunnyside is unglamorous, which is the point. You tell it your goal - maybe "no more than four drinks a week," maybe "dry weekdays" - and then you log your drinks. The app nudges you with daily check-ins, largely over plain SMS, which is a deliberate and slightly contrarian product choice: text messages sit in the same inbox as your friends, so accountability feels human rather than gamified. You can plan your drinking days in advance, which turns a vague intention into a concrete decision made while sober.
Behind the texts is a coaching layer that mixes real human coaches with an AI-assisted chat coach, plus a peer community where members trade encouragement. The community is the feature nobody screenshots but many people stay for; moderation is lonely work, and a group of strangers going through the same thing turns out to be a durable retention engine.
In 2024 the company added Sunnyside Med, a telehealth service where licensed providers can prescribe compounded naltrexone - a medication that quietly blunts alcohol cravings and has done so for decades - paired with the same tracking and coaching. Sunnyside didn't invent the drug. It did the more prosaic and valuable thing of putting the medicine, the data, and the humans in one place.
Member-reported outcomes
The business: $99 a year to feel a little better
Sunnyside is a direct-to-consumer subscription business, which is a clean and slightly perilous model - clean because you don't have to negotiate with insurers, perilous because you have to earn the renewal every year from someone whose goal, by design, is to think about your product less. Plans start around $99 a year for the basic app, step up for coaching, and reach roughly $99 a month for Sunnyside Med with prescription naltrexone. There's a free trial, because the entire funnel depends on you experiencing the small, unglamorous win of a lighter week.
One recurring growth engine is seasonal: "Dry(ish) January," the moderation-friendly cousin of the total-abstinence version, which conveniently arrives every year exactly when people are motivated to reconsider their habits. It's a trend that doubles as a customer-acquisition channel.
The money
In November 2023, Sunnyside raised an $11.5M Series A led by Motley Fool Ventures, with major participation from Will Ventures and a long tail of investors including Uncork Capital, Offline Ventures, Joyance Partners, Scribble Ventures, and - fittingly - Michael Lee, the founder of MyFitnessPal, a company that also turned "log the thing you're trying to change" into a habit. That round brought total funding to $14.6M. Part of the pitch was building out the AI coach.
You can read the investor thesis as slightly boring, which is a compliment. The bet isn't on a miracle. It's on the observation that a large population of ordinary drinkers has a mild, persistent, unaddressed problem, and that a modestly priced subscription that makes them 33% better off is a perfectly good business.
The competition, and the moat
Sunnyside isn't alone - Reframe, Ria Health's offerings, Monument, and Sober Sidekick all circle the same territory, and the ultimate incumbent is the free, ancient, abstinence-first world of AA. Sunnyside's differentiation is its refusal to demand quitting, plus the unusual full stack: tracking, human coaching, community, and medication under one login. Whether "we won't make you quit" is a durable moat or just a head start is the open question, but for now it has bought the company a category most of the industry ignored.
The honest caveat, which Sunnyside is reasonably upfront about: the marquee statistics are largely member-reported, individual results vary, and moderation is not appropriate for everyone with a serious alcohol use disorder. It is a tool for the large middle, not a treatment for the acute edge. That's a limitation and also, more or less, the entire business plan.
Why the boring approach is the point
There is a temptation, when writing about a wellness app, to reach for the transformation narrative - the rock bottom, the reckoning, the new person emerging. Sunnyside is structurally uninterested in that story, and its restraint is the most interesting thing about it. The product does not want you to have a crisis. It wants you to notice, on an ordinary Tuesday, that you were going to have a third drink and then didn't, and to feel slightly better on Wednesday. Multiply that small delta across 600,000 people and a few years and you get 24 million drinks that didn't happen, which is a large number assembled entirely out of unremarkable moments.
This is also why the tracking comes before the intervention. Most people genuinely do not know how much they drink; the honest answer is usually "more than I'd have guessed." Sunnyside's first job is not to change behavior but to make it visible, on the theory - borne out in fitness, in budgeting, in basically every domain where humans try to improve - that measurement alone moves the number. You log, you see, you adjust. The coaching and the community and the medication are all layered on top of that first, cheap, powerful act of paying attention.
What to watch next
The open questions are the ordinary ones for a subscription health company. Can Sunnyside keep members past the first honeymoon month, when the novelty of a lighter week fades into the grind of maintaining it? Does the AI coach - the thing the Series A was partly meant to fund - deepen the product or dilute the human warmth that makes SMS coaching work? And does adding a prescription arm turn a friendly consumer app into a regulated healthcare business, with all the compliance weight that implies? None of these are existential. All of them are the difference between a nice app and a category-defining company.
For now, Sunnyside occupies a strange and enviable position: it built a business on a goal the culture spent decades treating as illegitimate, and it turned out a lot of people were quietly waiting for someone to take that goal seriously. Drink less, not none. It is not a slogan that fits on a chip. It just happens to describe what most people actually want.